Viking Therapeutics, Inc. Viking Therapeutics, Inc.

Viking Therapeutics, Inc.

VKTX

Helyezés a részvények között #4520
Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.
Részvényárfolyam
$25.99
Piaci kapitalizáció
$3.31B
Változás (1 nap)
-1.47%
Változás (1 év)
-17.27%
Ország
US
Kereskedés Viking Therapeutics, Inc. (VKTX)

Kategória

Healthcare
Viking Therapeutics, Inc. (VKTX) részvényárfolyamának története
Legmagasabb napi záróár: $27.50 ekkor: 2026-10-01

Legalacsonyabb napi záróár: $8.59 ekkor: 2015-04-01
Viking Therapeutics, Inc. részvényárfolyamának története 2015 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) -7.92%
2025 -20.83%
2024 152.59%
2023 215.71%
2022 16.84%
2021 -21.08%
2020 -20.48%
2019 -10.51%
2018 130.53%
2017 246.93%
2016 -60.36%
2015 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $530.66 24.44%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $230.18 757.28%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $137.83 -3.78%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $890.66 9.40%
NL
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $290.41 2.03%
BE